State of Wisconsin Investment Board’s Ocular Therapeutix OCUL Stock Holding History

State of Wisconsin Investment Board’s Portfolio OCUL Stock Details OCUL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$940K	Sell	111,005 -51,805	-32%	-$494K	﹤0.01%	1722
2025 Q4	$1.98M	Buy	162,810 +37,616	+30%	+$457K	﹤0.01%	1417
2025 Q3	$1.46M	Sell	125,194 -1,487	-1%	-$17.8K	﹤0.01%	1475
2025 Q2	$1.18M	Sell	126,681 -72,349	-36%	-$566K	﹤0.01%	1514
2025 Q1	$1.46M	Buy	199,030 +18,794	+10%	+$144K	﹤0.01%	1360
2024 Q4	$1.54M	Sell	180,236 -11,921	-6%	-$116K	﹤0.01%	1376
2024 Q3	$1.67M	Sell	192,157 -49,791	-21%	-$410K	﹤0.01%	1383
2024 Q2	$1.65M	Buy	241,948 +186,748	+338%	+$1.15M	﹤0.01%	1377
2024 Q1	$502K	Buy	+55,200	New	+$392K	﹤0.01%	1756
2023 Q1	–	Sell	-105,800	Closed	-$297K	–	2571
2022 Q4	$297K	Sell	105,800 -63,612	-38%	-$211K	﹤0.01%	2102
2022 Q3	$703K	Sell	169,412 -59,865	-26%	-$302K	﹤0.01%	1766
2022 Q2	$922K	Buy	229,277 +48,577	+27%	+$184K	﹤0.01%	1683
2022 Q1	$894K	Buy	180,700 +95,500	+112%	+$529K	﹤0.01%	1664
2021 Q4	$594K	Sell	85,200 -29,800	-26%	-$231K	﹤0.01%	1626
2021 Q3	$1.15M	Buy	115,000 +8,900	+8%	+$100K	﹤0.01%	1412
2021 Q2	$1.5M	Buy	106,100 +4,300	+4%	+$65.4K	﹤0.01%	1347
2021 Q1	$1.67M	Buy	101,800 +1,400	+1%	+$27K	﹤0.01%	1268
2020 Q4	$2.08M	Sell	100,400 -6,500	-6%	-$96.5K	﹤0.01%	1192
2020 Q3	$813K	Buy	106,900 +32,500	+44%	+$270K	﹤0.01%	1341
2020 Q2	$620K	Buy	74,400 +600	+0.8%	+$3.98K	﹤0.01%	1363
2020 Q1	$365K	Buy	+73,800	New	+$364K	﹤0.01%	1429
2019 Q3	–	Sell	-45,600	Closed	-$201K	–	1574
2019 Q2	$201K	Buy	45,600 +1,000	+2%	+$3.7K	﹤0.01%	1486
2019 Q1	$177K	Buy	44,600 +10,200	+30%	+$41K	﹤0.01%	1471
2018 Q4	$137K	Buy	34,400 +16,400	+91%	+$90.4K	﹤0.01%	1480
2018 Q3	$124K	Hold	18,000	–	–	﹤0.01%	1517
2018 Q2	$121K	Hold	18,000	–	–	﹤0.01%	1450
2018 Q1	$117K	Hold	18,000	–	–	﹤0.01%	1425
2017 Q4	$80K	Hold	18,000	–	–	﹤0.01%	1433
2017 Q3	$111K	Hold	18,000	–	–	﹤0.01%	1436
2017 Q2	$167K	Buy	+18,000	New	+$174K	﹤0.01%	1411

Other funds holding OCUL

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

State of Wisconsin Investment Board's OCUL Position: Q1 2026 in Review

State of Wisconsin Investment Board reduced its Ocular Therapeutix (OCUL) stake by 32% in Q1 2026, selling an estimated $494K and leaving 111,005 shares worth $940K. The position accounts for ﹤0.01% of the portfolio, ranked #1722.

State of Wisconsin Investment Board first reported a position in OCUL in Q2 2017 and has held it in 30 quarters since. The position peaked at $2.08M in Q4 2020. 269 funds tracked by Wall St. Rank hold OCUL as of Q1 2026.

State of Wisconsin Investment Board held 111,005 shares of Ocular Therapeutix worth $940K as of Q1 2026.
State of Wisconsin Investment Board sold 51,805 Ocular Therapeutix shares in Q1 2026, an estimated $494K.
Ocular Therapeutix made up ﹤0.01% of State of Wisconsin Investment Board's portfolio in Q1 2026, its #1722 holding.
State of Wisconsin Investment Board first reported a position in Ocular Therapeutix in Q2 2017 and has held it in 30 quarters since.
State of Wisconsin Investment Board's Ocular Therapeutix position peaked at $2.08M in Q4 2020.
269 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q1 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.